The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.
Altria removed one risk related to JUUL divestiture challenges while substantively modifying eight existing risks, with no new risks added, reflecting a net reduction in disclosed risk categories. The most significant modifications expanded disclosure on cybersecurity and information systems vulnerabilities, elevated concerns about investor expectations regarding corporate responsibility performance, and refined competitive positioning language. This shift suggests Altria is consolidating its risk narrative while deepening focus on operational resilience and stakeholder perception management rather than introducing fundamentally new business threats.
Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.
🔴 No Match in Current Filing
A challenge to our investment in JUUL, if successful, could result in a broad range of resolutions, including divestiture of the investment or rescission of the transaction.
🔒
🟡 Modified
The failure of our, or our service providers’, key suppliers’ or trade customers’, information systems to function as intended, or cyber-attacks or security breaches, could have a material adverse effect on our business, reputation, results of operations, cash flows or financial position.
🔒
🟡 Modified
We may be unable to attract investors due to increasing investor expectations of our performance relating to corporate responsibility factors.
🔒
🟡 Modified
We face significant competition, and our failure to compete effectively could have a material adverse effect on our business, results of operations, cash flows or financial position and our ability to achieve our Vision.
🔒
🟡 Modified
Unfavorable outcomes with respect to litigation proceedings or any governmental investigations could materially adversely affect our results of operations, cash flows or financial position and our ability to achieve our Vision.
🔒
🟡 Modified
Failure to complete or manage strategic transactions, including acquisitions, dispositions, joint ventures and investments in third parties, or realize the anticipated benefits of such transactions, could have a material adverse effect on our business, financial position and our ability to achieve our Vision.
🔒
🟡 Modified
We may be unsuccessful in commercializing innovative products, including tobacco products with reduced health risks relative to certain other tobacco products and that appeal to adult tobacco consumers, which may have a material adverse effect on our business, results of operations, cash flows or financial position and our ability to achieve our Vision.
🔒
🟡 Modified
Significant federal, state and local governmental actions, including FDA regulatory actions and inaction, and various private sector actions may continue to have a material adverse impact on our operating companies’ sales volumes and our business.
🔒
🟡 Modified
Our failure, or the failure of our service providers, key suppliers or trade customers, to comply with personal data protection, privacy, artificial intelligence and information security laws could materially adversely affect our business.
🔒